Quest Diagnostics Inc
NYSE:DGX
Operating Margin
Quest Diagnostics Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
20.1B USD |
14%
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
73.8B EUR |
4%
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
84B USD |
3%
|
|
| US |
|
Cigna Corp
NYSE:CI
|
84.8B USD |
4%
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
27.2B EUR |
7%
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.7B EUR |
9%
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD |
9%
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
13.6B EUR |
7%
|
|
| US |
|
Hims & Hers Health Inc
NYSE:HIMS
|
14.4B USD |
6%
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD |
15%
|
|
| AU |
|
Sonic Healthcare Ltd
ASX:SHL
|
12.7B AUD |
10%
|
Quest Diagnostics Inc
Glance View
In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Quest Diagnostics Inc's most recent financial statements, the company has Operating Margin of 14.4%.
You don't have any saved screeners yet